<DOC>
	<DOCNO>NCT00421226</DOCNO>
	<brief_summary>This study evaluate safety , tolerability , pharmacokinetics pharmacodynamics ACZ885 administer via intravenous infusion subcutaneous injection healthy Japanese male volunteer .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Pharmacodynamics ACZ885 Healthy Japanese Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Japanese healthy male subject age 20 45 year age , good health At screen baseline , subject must good health determine past medical history , physical examination , electrocardiogram , laboratory test urinalysis . Body mass index within range 18 28 kg/m2 weigh 50 100 kg Smokers . Use prescription drug within 4 week prior dose , overthecounter medication ( vitamin , herbal supplement , dietary supplement ) within 2 week prior dose . Acetaminophen acceptable . Treatment biologics within three month prior dose . Having live vaccination within six month prior dose . Participation clinical investigation within 4 month prior dose . Donation loss 400 mL blood within 3 month ; donation loss 200 mL blood within 1 month ; donation component blood within 2 week prior participation . Significant illness ( sinusitis , pneumonia , cystitis , sepsis , etc ) within two week prior dose . A past personal close family medical history cardiac disorder History : fainting , low blood pressure standing , abnormal heart rhythms acute chronic bronchospastic disease ( include asthma chronic obstructive pulmonary disease , treat treat ) . Clinically significant drug allergy history complication atopic allergy ( asthma , urticaria , eczematous dermatitis ) Known hypersensitivity study drug similar drug Any surgical medical condition might significantly alter absorption , distribution , metabolism excretion drug jeopardize participation study . History immunodeficiency disease , include positive HIV test result . A positive Hepatitis B surface antigen ( HBsAg ) , Hepatitis C Syphilis test result . Drug alcohol abuse within 12 month prior dose Tuberculosis symptom , complication tuberculosis , contact patient suspect tuberculosis symptom Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Safety , tolerability , pharmacokinetics , pharmacodynamics , ACZ885 , Japanese ,</keyword>
</DOC>